Dornier provides limited operational support services, such as process improvements for manufacturing and quality standards, for the WIKKON product. Dornier is not the manufacturer of WIKKON product and has no role in its design, technology, production, or quality assurance. The WIKKON products is manufactured, warranted, and solely controlled by WIKKON. WIKKON is solely responsible for…
On September 5, 2025, the WIKKON New Brand Launch Event was successfully held at the Dornier/WIKKON booth during the 32nd Annual Meeting of the Chinese Urological Association (CUA2025). The event, themed “Empowering Healthcare with Advanced Solutions” officially unveiled WIKKON’s new brand identity—an important step in WIKKON’s ongoing expansion of products and services in international…
Singapore and Shenzhen, China, 30 June 2025 – WIKKON®, China’s market leader in urology and shock wave therapy devices, today announced U.S. FDA 510(k) clearance for its U200 Extracorporeal Shock Wave Lithotripter. This marks a key turning point for the company and reinforces its readiness to expand globally, as FDA clearance is widely recognized as…
The “Harmony in Healthcare: The 2024 National Conference on Anti-Aging, Alternative Medicine, Aesthetic Medicine, and Wellness” (SMART) took place in Thailand from July 20th to 21st. This prestigious international conference is a leading platform for the exchange of advancements in medical technology, focusing on anti-aging, alternative medicine, aesthetic medicine, and overall wellness. At this year’s…
The 8th Annual Academic Conference of the Andrology Branch of the Hangzhou Medical Association was recently held in Hangzhou, Zhejiang. At this significant event, the multi-center research project focusing on the treatment of vascular erectile dysfunction (ED) using the low-energy extracorporeal shock wave E300 was officially inaugurated. This important research initiative is spearheaded by Hangzhou…
Wikkon is pleased to announce the successful installation of the new HK.ESWL-V lithotripsy machine at the Urology Center of National Hospital in Bishkek, Kyrgyzstan. This cutting-edge device, featuring advanced dual localization capabilities with both X-ray and ultrasound, marks a significant technological milestone as the first of its kind in the capital city. The collaboration between…
Singapore and Shenzhen, China, 13 September 2022 – Integrated urology leader Advanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in WIKKON, the Chinese market leader in urology and shock wave therapy devices. AMTH expects to acquire the remaining shares of WIKKON by the end of 2022. Based in the tech…
On March 14, 2022 , Wikkon successfully installed the latest extracorporeal shock wave lithotripter, model HK.ESWL – 108A at Maria Clinic, In Dili, East Timor. Maria Clinic was founded in 2014 by Dr. Xiao, who has rich clinical experience. It is one of the earliest comprehensive clinics in East Timor. It provides high-quality and efficient…
On February 18, 2022, Wikkon’s latest extracorporeal shock wave lithotripter, model HK.ESWL-108A was successfully installed in Jakarta, the capital of Indonesia. HK.ESWL-108A is the most cost-effective ESWL, with a treatment table, shockwave unit, and ultrasound imaging system all integrated into one unit. Wikkon has made a new upgrade for HK.ESWL-108A . It adopts a user-friendly…
The 28th Chinese Urological Association Annual Meeting was held from Oct. 21 – 24, 2021, at Nanjing International Exhibition Center, Nanjing China. The CUA annual meeting was one of the largest urology gatherings in Asia which attracted more than 2000 urologists. As Chinese leading supplier of medical devices, Wikkon attended this congress and exhibited its…
